Article

You have full text access to this OnlineOpen article

Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: Catalase, peroxidase, and INH-NADH adduct formation activities

  1. Christine E. Cade1,
  2. Adrienne C. Dlouhy1,
  3. Katalin F. Medzihradszky2,
  4. Saida Patricia Salas-Castillo2,
  5. Reza A. Ghiladi1,*

Article first published online: 6 JAN 2010

DOI: 10.1002/pro.324

Issue

Protein Science

Protein Science

Volume 19, Issue 3, pages 458–474, March 2010

Additional Information

How to Cite

Cade, C. E., Dlouhy, A. C., Medzihradszky, K. F., Salas-Castillo, S. P. and Ghiladi, R. A. (2010), Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: Catalase, peroxidase, and INH-NADH adduct formation activities. Protein Science, 19: 458–474. doi: 10.1002/pro.324

Author Information

  1. 1

    Department of Chemistry, North Carolina State University, Raleigh, North Carolina 27695-8204

  2. 2

    Department of Pharmaceutical Chemistry, University of California, San Francisco, California 94158-2517

*Department of Chemistry, Dabney Hall, North Carolina State University, Campus Box 8204, Raleigh, NC 27695-8204

Publication History

  1. Issue published online: 22 FEB 2010
  2. Article first published online: 6 JAN 2010
  3. Accepted manuscript online: 6 JAN 2010 12:00AM EST
  4. Manuscript Accepted: 11 DEC 2009
  5. Manuscript Revised: 30 NOV 2009
  6. Manuscript Received: 27 AUG 2009

Funded by

  • NIH/NIAID. Grant Number: N01 AI-75320

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (505K)

References

  • 1
    Report No. 4 ( 2008) Anti-tuberculosis drug resistance in the World. Geneva, Switzerland: World Health Organization.
  • 2
    LoBue P, Sizemore C, Castro KG. Plan to combat extensively drug-resistant tuberculosis: recommendations of the federal tuberculosis task force ( 2009). MMWR Recomm Rep 58: 1–43.
  • 3
    Scior T, Meneses Morales I, Garces Eisele SJ, Domeyer D, Laufer S ( 2002) Antitubercular isoniazid and drug resistance of Mycobacterium tuberculosis: a review. Arch Pharm Pharm Med Chem 11: 511–525.
  • 4
    Vilcheze C, Jacobs WR, Jr ( 2007) The mechanism of isoniazid killing: clarity through the scope of genetics. Annu Rev Microbiol 61: 35–50.
  • 5
    Slayden RA, Barry CE, III ( 2000) The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis. Microbes Infect 2: 659–669.
  • 6
    Rozwarski DA, Grant GA, Barton DHR, Jacobs WR, Jr, Sacchettini JC ( 1998) Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis. Science 279: 98–102.
  • 7
    Ducasse-Cabanot S, Cohen-Gonsaud M, Marrakchi H, Nguyen M, Zerbib D, Bernadou J, Daffe M, Labesse G, Quemard A ( 2004) In vitro inhibition of the Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein reductase MabA by isoniazid. Antimicrob Agents Chemother 48: 242–249.
  • 8
    Quémard A, Sacchettini JC, Dessen A, Vilcheze C, Bittman R, Jacobs WR, Jr, Blanchard JS ( 1995) Enzymatic characterization of the target of isoniazid in Mycobacterium tuberculosis. Biochemistry 34: 8235–8241.
  • 9
    Quémard A, Lacave C, Canéelle G ( 1991) Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum. Antimicrob Agents Chemother 35: 1035–1039.
  • 10
    Wei C-J, Lei B, Musser JM, Tu S-C ( 2003) Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production. Antimicrob Agents Chemother 47: 670–675.
  • 11
    Musser JM ( 1995) Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 8: 496–514.
  • 12
    Rouse DA, DeVito JA, Li Z, Byer H, Morris SL ( 1996) Site-directed mutagenesis of the katG gene of Mycobacterium tuberculosis: effects on catalase-peroxidase activities and isoniazid resistance. Mol Microb 22: 583–592.
  • 13
    Ramaswamy S, Musser JM ( 1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 Update. Tubercle Lung Dis 79: 3–29.
  • 14
    Ghiladi RA, Medzihradszky KF, Rusnak FM, Ortiz de Montellano PR ( 2005) Correlation between isoniazid resistance and superoxide reactivity in Mycobacterium tuberculosis KatG. J Am Chem Soc 127: 13428–13442.
  • 15
    Metcalfe C, Macdonald IK, Murphy EJ, Brown KA, Raven EL, Moody PC ( 2008) The tuberculosis prodrug isoniazid bound to activating peroxidases. J Biol Chem 283: 6193–6200.
  • 16
    Welinder KG ( 1991) Bacterial catalase-peroxidases are gene duplicated members of the plant peroxidase superfamily. Biochim Biophys Acta 1080: 215–220.
  • 17
    Zhao X, Yu H, Yu S, Wang F, Sacchettini JC, Magliozzo RS ( 2006) Hydrogen peroxide-mediated isoniazid activation catalyzed by Mycobacterium tuberculosis catalase-peroxidase (KatG) and its S315T mutant. Biochemistry 45: 4131–4140.
  • 18
    Chouchane S, Lippai I, Magliozzo RS ( 2000) Catalase-peroxidase (Mycobacterium tuberculosis KatG) catalysis and isoniazid activation. Biochemistry 39: 9975–9983.
  • 19
    Ghiladi RA, Knudsen GM, Medzihradszky KF, Ortiz de Montellano PR ( 2005) The Met-Tyr-Trp cross-link in Mycobacterium tuberculosis catalase-peroxidase (KatG): autocatalytic formation and effect on enzyme catalysis and spectroscopic properties. J Biol Chem 280: 22651–22663.
  • 20
    Yu S, Girotto S, Zhao X, Magliozzo RS ( 2003) Rapid formation of compound II and a tyrosyl radical in the Y229F mutant of Mycobacterium tuberculosis catalase-peroxidase disrupts catalase but not peroxidase function. J Biol Chem 278: 44121–44127.
  • 21
    Jakopitsch C, Wanasinghe A, Jantschko W, Furtmueller PG, Obinger C ( 2005) Kinetics of interconversion of ferrous enzyme, compound II and compound III of wild-type synechocystis catalase-peroxidase and Y249F. Proposal for the catalytic mechanism. J Biol Chem 280: 9037–9042.
  • 22
    Ghiladi RA, Medzihradszky KF, Ortiz de Montellano PR ( 2005) The role of the Met-Tyr-Trp crosslink in Mycobacterium tuberculosis catalase-peroxidase (KatG) as revealed by KatG(M255I). Biochemistry 44: 15093–15105.
  • 23
    Singh R, Wiseman B, Deemagarn T, Donald LJ, Duckworth HW, Carpena X, Fita I, Loewen PC ( 2004) Catalase-peroxidases (KatG) exhibit NADH oxidase activity. J Biol Chem 279: 43098–43106.
  • 24
    Wengenack NL, Jensen MP, Rusnak F, Stern MK ( 1999) Mycobacterium tuberculosis KatG is a Peroxynitritase. Biochem Biophys Res Commun 256: 485–487.
  • 25
    Magliozzo RS, Marcinkeviciene JA ( 1997) The role of Mn(II)-peroxidase activity of mycobacterial catalase-peroxidase in activation of the antibiotic isoniazid. J Biol Chem 272: 8867–8870.
  • 26
    Magliozzo RS, Marcinkeviciene JA ( 1996) Evidence for isoniazid oxidation by oxyferrous mycobacterial catalase-peroxidase. J Am Chem Soc 118: 11303–11304.
  • 27
    Wengenack NL, Hoard HM, Rusnak F ( 1999) Isoniazid oxidation by Mycobacterium tuberculosis KatG: a role for superoxide which correlates with isoniazid susceptibility. J Am Chem Soc 121: 9748–9749.
  • 28
    Ghiladi RA, Cabelli DE, Ortiz de Montellano PR ( 2004) Superoxide reactivity of KatG: insights into isoniazid resistance pathways in TB. J Am Chem Soc 126: 4772–4773.
  • 29
    Yu S, Chouchane S, Magliozzo RS ( 2002) Characterization of the W321F mutant of Mycobacterium tuberculosis catalase-peroxidase KatG. Protein Sci 11: 58–64.
  • 30
    Wengenack NL, Uhl JR, St. Amand AL, Tomlinson AJ, Benson LM, Naylor S, Kline BC, Cockerill FR, III, Rusnak F ( 1997) Recombinant Mycobacterium tuberculosis KatG(S315T) is a competent catalase-peroxidase with reduced activity toward isoniazid. J Infect Dis 176: 722–727.
  • 31
    Jakopitsch C, Kolarich D, Petutschnig G, Furtmuller PG, Obinger C ( 2003) Distal side tryptophan, tyrosine and methionine in catalase-peroxidases are covalently linked in solution. FEBS Lett 552: 135–140.
  • 32
    Dumarieh R, Smirnov T, Ghiladi RA (submitted) Catalytic relevance of the sulfonium ion in the Met-Tyr-Trp crosslink of Mycobacterium tuberculosis catalase-peroxidase (KatG).
  • 33
    Nicholls P, Fita I, Loewen P, Enzymology and structure of catalases. In: SykesAG, MaukG, editors. ( 2001) Advances in inorganic chemistry: heme-fe proteins. Academic Press, San Diego, CA. pp 51–106.
  • 34
    Mate MJ, Murshudov G, Bravo J, Melik-Adamyan W, Loewen PC, Fita I Heme-catalases. In: MesserschmidtA, HuberR, PoulosTL, et al., editors. ( 2001) Handbook of metalloproteins. Chichester: John Wiley and Sons, Inc., pp 486–502.
  • 35
    Bertrand T, Eady NAJ, Jones JN, Jesmin, Nagy JM, Jamart-Grégoire B, Raven EL, Brown KA ( 2004) Crystal structure of Mycobacterium tuberculosis catalase-peroxidase. J Biol Chem 279: 38991–38999.
  • 36
    Jakopitsch C, Ivancich A, Schmuckenschlager F, Wanasinghe A, Poltl G, Furtmuller PG, Ruker F, Obinger C ( 2004) Influence of the unusual covalent adduct on the kinetics and formation of radical intermediates in synechocystis catalase peroxidase: a stopped-flow and EPR characterization of the MET275, TYR249, and ARG439 variants. J Biol Chem 279: 46082–46095.
  • 37
    Jakopitsch C, Auer M, Ivancich A, Ruker F, Furtmuller PG, Obinger C ( 2003) Total conversion of bifunctional catalase-peroxidase (KatG) to monofunctional peroxidase by exchange of a conserved distal side tyrosine. J Biol Chem 278: 20185–20191.
  • 38
    Li Y, Goodwin DC ( 2004) Vital roles of an interhelical insertion in catalase-peroxidase bifunctionality. Biochem Biophys Res Commun 318: 970–976.
  • 39
    Vidossich P, Alfonso-Prieto M, Carpena X, Loewen PC, Fita I, Rovira C ( 2007) Versatility of the electronic structure of compound I in catalase-peroxidases. J Am Chem Soc 129: 13436–13446.
  • 40
    Deemagarn T, Wiseman B, Carpena X, Ivancich A, Fita I, Loewen PC ( 2007) Two alternative substrate paths for compound I formation and reduction in catalase-peroxidase KatG from Burkholderia pseudomallei. Proteins 66: 219–228.
  • 41
    Carpena X, Wiseman B, Deemagarn T, Herguedas B, Ivancich A, Singh R, Loewen PC, Fita I ( 2006) Roles for Arg426 and Trp111 in the modulation of NADH oxidase activity of the catalase-peroxidase KatG from Burkholderia pseudomallei inferred from pH-induced structural changes. Biochemistry 45: 5171–5179.
  • 42
    Suarez J, Ranguelova K, Jarzecki AA, Manzerova J, Krymov V, Zhao X, Yu S, Metlitsky L, Gerfen GJ, Magliozzo RS ( 2009) An oxyferrous heme/protein-based radical intermediate is catalytically competent in the catalase reaction of Mycobacterium tuberculosis catalase-peroxidase (KatG). J Biol Chem 284: 7017–7029.
  • 43
    Zhao X, Yu S, Ranguelova K, Suarez J, Metlitsky L, Schelvis JP, Magliozzo RS ( 2009) Role of the oxyferrous heme intermediate and distal side adduct radical in the catalase activity of Mycobacterium tuberculosis KatG revealed by the W107F mutant. J Biol Chem 284: 7030–7037.
  • 44
    Nguyen M, Quemard A, Broussy S, Bernadou J, Meunier B ( 2002) Mn(III) Pyrophosphate as an efficient tool for studying the mode of action of isoniazid on the InhA protein of Mycobacterium tuberculosis. Antimicrob Agents Chemother 46: 2137–2144.
  • 45
    Nguyen M, Claparols C, Bernadou J, Meunier B ( 2001) A fast and efficient metal-mediated oxidation of isoniazid and identification of isoniazid-NAD(H) adducts. Chem Biochem 2: 877–883.
  • 46
    Lei B, Wei C-J, Tu S-C ( 2000) Action mechanism of antitubercular isoniazid. J Biol Chem 275: 2520–2526.
  • 47
    Halliwell B, Gutteridge JMC ( 1999) Free radicals in biology and medicine, 3rd ed. Oxford: Oxford University Press.
  • 48
    van der Walt BJ, van Zyl JM, Kriegler A ( 1994) Different oxidative pathways of isonicotinic acid hydrazide and its meta-isomer, nicotinic acid hydrazide. Int J Biochem 26: 1081–1093.
  • 49
    Hill HA, Thornalley PJ ( 1981) Phenyl radical production during the oxidation of phenylhydrazine and in phenylphydrazine-induced hemolysis. FEBS Lett 125: 235–238.
  • 50
    Winder FG, Denneny JM ( 1959) Metal-catalyzed auto-oxidation of isoniazid. Biochem J 73: 500–507.
  • 51
    Ranguelova K, Suarez J, Magliozzo RS, Mason RP ( 2008) Spin trapping investigation of peroxide- and isoniazid-induced radicals in Mycobacterium tuberculosis catalase-peroxidase. Biochemistry 47: 11377–11385.
  • 52
    Suarez J, Ranguelova K, Schelvis JP, Magliozzo RS ( 2009) Antibiotic resistance in Mycobacterium tuberculosis: peroxidase intermediate bypass causes poor isoniazid activation by the S315G mutant of M. tuberculosis catalase-peroxidase (KatG). J Biol Chem 284: 16146–16155.
  • 53
    SuzukiK, editor ( 2000). Superoxide-generating system. Oxford: Oxford University Press.
  • 54
    Rouse DA, Li Z, Bai G-H, Morris SL ( 1995) Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 39: 2472–2488.
  • 55
    Heym B, Alzari PM, Honoré N, Cole ST ( 1995) Missense mutations in the catalase-peroxidase gene, katG, are associated with isoniazid resistance in Mycobacterium tuberculosis. Mol Microbiol 15: 235–245.
  • 56
    Musser JM, Kapur V, Williams DL, Kreiswirth BN, van Soolingen D, van Embden JDA ( 1996) Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 173: 196–202.
  • 57
    Haas WH, Schilke K, Brand J, Amthor B, Weyer K, Fourie PB, Bretzel G, Sticht-Groh V, Bremer HJ ( 1997) Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob Agents Chemother 41: 1601–1603.
  • 58
    Marttila HJ, Soini H, Huovinen P, Viljanen MK ( 1996) katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother 40: 2187–2189.
  • 59
    Morris S, Bai GH, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D ( 1995) Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 171: 954–960.
  • 60
    Gagneux S, Burgos MV, DeRiemer K, Encisco A, Munoz S, Hopewell PC, Small PM, Pym AS ( 2006) Impact of bacterial genetics on the transmission of isoniazid-resistant Mycobacterium tuberculosis. PLoS Pathog 2: e61.
  • 61
    Cockerill FR, III, Uhl JR, Temesgen Z, Zhang Y, Stockman L, Roberts GD, Williams DL, Kline BC ( 1994) Rapid identification of a point mutation of the Mycobacterium tuberculosis catalase-peroxidase (katG) gene associated with isoniazid resistance. J Infect Dis 171: 240–245.
  • 62
    Wengenack NL, Lane BD, Hill PJ, Uhl JR, Lukat-Rodgers GS, Hall L, Roberts GD, Cockerill FR, 3rd, Brennan PJ, Rodgers KR, Belisle JT, Rusnak F ( 2004) Purification and characterization of Mycobacterium tuberculosis KatG, KatG(S315T), and Mycobacterium bovis KatG(R463L). Protein Expr Purif 36: 232–243.
  • 63
    Doustdar F, Khosravi AD, Farnia P, Masjedi MR, Velayati AA ( 2008) Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran. Microb Drug Resist 14: 273–279.
  • 64
    Wojtyczka RD, Dworniczak S, Pacha J, Idzik D, Kepa M, Wydmuch Z, Glab S, Bajorek M, Oklek K, Kozielski J ( 2004) PCR-RFLP analysis of a point mutation in codons 315 and 463 of the katG gene of Mycobacterium tuberculosis isolated from patients in Silesia, Poland. Pol J Microbiol 53: 89–93.
  • 65
    Yu S, Girotto S, Lee C, Magliozzo RS ( 2003) Reduced affinity for Isoniazid in the S315T mutant of Mycobacterium tuberculosis KatG is a key factor in antibiotic resistance. J Biol Chem 278: 14769–14775.
  • 66
    Pym AS, Saint-Joanis B, Cole ST ( 2002) Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 70: 4955–4960.
  • 67
    Smulevich G, Jakopitsch C, Droghetti E, Obinger C ( 2006) Probing the structure and bifunctionality of catalase-peroxidase (KatG). J Inorg Biochem 100: 568–585.
  • 68
    Singh R, Switala J, Loewen PC, Ivancich A ( 2007) Two [Fe(IV)=O Trp*] intermediates in Mycobacterium tuberculosis catalase-peroxidase discriminated by multifrequency (9–285 GHz) EPR spectroscopy: reactivity toward isoniazid. J Am Chem Soc 129: 15954–15963.
  • 69
    Kapetanaki SM, Chouchane S, Yu S, Zhao X, Magliozzo RS, Schelvis JP ( 2005) Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function. Biochemistry 44: 243–252.
  • 70
    Saint-Joanis B, Souchon H, Wilming M, Johnsson K, Alzari PM, Cole ST ( 1999) Use of site-directed mutagenesis to probe the structure, function, and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis. Biochem J 338: 753–760.
  • 71
    Baker RD, Cook CO, Goodwin DC ( 2004) Properties of catalase-peroxidase lacking its C-terminal domain. Biochem Biophys Res Commun 320: 833–839.
  • 72
    Nagy JM, Cass AEG, Brown KA ( 1997) Purification and characterization of recombinant catalase-peroxidase, which confers isoniazid sensitivity in Mycobacterium tuberculosis. J Biol Chem 272: 31265–31271.
  • 73
    Johnsson K, Froland WA, Schultz PG ( 1997) Overexpression, purification, and characterization of the catalase-peroxidase KatG from Mycobacterium tuberculosis. J Biol Chem 272: 2834–2840.
  • 74
    Beers RF, Jr, Sizer IW ( 1952) A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195: 133–140.
  • 75
    Childs RE, Bardsley WG ( 1975) The steady state kinetics of peroxidase with 2,2′-azino-di-(3-ethyl-benzthiazoline-6-sulphonic acid) as chromogen. Biochem J 145: 93–103.
  • 76
    Broussy S, Bernardes-Genisson V, Coppel Y, Quemard A, Bernadou J, Meunier B ( 2005) 1H and 13C NMR characterization of pyridinium-type isoniazid-NAD adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis. Org Biomol Chem 3: 670–673.
  • 77
    Broussy S, Coppel Y, Nguyen M, Bernadou J, Meunier B ( 2003) 1H and 13C NMR characterization of hemiamidal isoniazid-NAD(H) adducts as possible inhibitors of InhA reductase of Mycobacterium tuberculosis. Chemistry 9: 2034–2038.
View Full Article with Supporting Information (HTML) Get PDF (505K)